BUY Syngene International Limited — Kotak Securities
byKotak SecuritiesHorizon: NA (inferred 1 year)26 Oct 2026via Financial Express Market
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Syngene International shares surge 12%, biggest 1-day gain in 6 years; what drove the rally despite a Q2 profit drop?
NewsLivemint·28 Oct · today
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·1 Sept · 2mo ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·28 Oct · today
Syngene International Q2 Results: Net profit tanks 52% on lower Zoetis revenue, forex hedge losses
NewsCnbc-Tv18·27 Oct · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Syngene International
- BUY — Rahul Sharma, JM Financial21 Oct 2026 · ~2 weeks · target ₹440 · SL hit
- BUY — Nirav Chheda, Nirmal Bang Securities13 Oct 2026 · ~2 weeks · target ₹410 · SL hit
- BUY — Goldman Sachs1 Sept 2026 · ~1 year · target ₹450 · Active
- BUY — Jatin Gedia, TM Investment Technologies27 Aug 2026 · ~2 weeks · target ₹430 · SL hit
- BUY — Macquarie30 Jul 2026 · ~1 year · target ₹735 · Active
More from Kotak Securities
- SELL Mazagon Dock Shipbuilders28 Oct 2026 · ~1 year · target ₹1,660 · Active
- BUY Mankind Pharma27 Oct 2026 · ~1 year · target ₹3,035 · Active
- SELL Sona BLW Precision Forgings27 Oct 2026 · ~1 year · target ₹700 · Active
- SELL Laurus Labs26 Oct 2026 · ~1 year · target ₹1,255 · Active
- SELL Divi's Laboratories26 Oct 2026 · ~1 year · target ₹7,560 · Active

